Lipoproteins mediate most of the lipid transport in the circulation of animals. In mammals, a single protein component, the nonexchangeable apolipoprotein B (apoB), provides the structural basis for the biosynthesis of neutral fattransporting lipoproteins (1, 2). Interestingly, the major lipoprotein of insects, lipophorin, contains two structural apolipoproteins, because the insect apoB homolog (3, 4), the precursor apolipophorin-II/I (apoLp-II/I), is cleaved during lipoprotein biosynthesis by the fat body (5, 6).
biosynthesis in insects as well. Therefore, we hypothesized that the cleavage of apoLp-II/I in the LLT domain functions in the biosynthesis and secretion of insect lipoprotein.
In the present report, we characterize the involvement of insect furin in the cleavage of L. migratoria apoLp-II/I and investigate the importance of this posttranslational modification to insect lipoprotein biosynthesis and secretion. To this end, apoLp-II/I cleavage was investigated in a recombinant insect expression system for truncated apoLp-II/I as well as in the locust fat body, the insect tissue that expresses apoLp-II/I and secretes its cleavage products apoLp-I and -II together in the form of a high density lipophorin (HDLp) particle (6, 13) . The results indicate that L. migratoria apoLp-II/I is cleaved by an insect furin. Uncleaved apoLp-II/I could be secreted and formed a high density lipoprotein. We conclude that cleavage of apoLp-II/I is not required for the biosynthesis and secretion of mature lipophorin. Rather, this posttranslational modification may represent a molecular adaptation enabling specific features of insect lipoproteins. Modeling of apoLp-II/I to the available homologous structures, the lipovitellin crystal structure and an apoB model, indicated the position of the cleavage site in the apoLp-II/I structure, and putative functions for apoLp-II/I cleavage are discussed accordingly.
MATERIALS AND METHODS

Construction of the apoLp-II/I-38 expression plasmid
Standard cloning and sequencing procedures (10, 14) were used to obtain an expression construct for L. migratoria apoLp-II/I. The apoLp-II/I-38 truncation variant was constructed by cloning the large Eco RI-Xho I cDNA fragment from pBK-CMV cDNA clone B20 (10) into pGEM7-Zf ϩ (Promega). Subsequently, this fragment was transferred to plasmid pALTER-1 (Promega) using Xba I and Sma I digestion. The Kpn I-Xho I fragment of this plasmid, encoding apoLp-II/I, was cloned into the insect cell expression vector pIZ/V5-His (Invitrogen) using the same restriction sites, yielding plasmid pIZ/V5-His-mod1. Subsequently, a short Xho I-Sac II primer fragment, containing a Bgl II site, was cloned into pIZ/V5-His-mod1, 3 Ј of the cDNA, to allow fusion of the open reading frame of the apoLp-II/I cDNA sequence with the V5 epitope and His tag, yielding pIZ/V5-His-mod1* (oligonucleotide sequences of the Xho I-Sac II primer fragment are 5 Ј -TCGAG-GCATGCAGATCTGGCCCGC-3 Ј and 5 Ј -GGGCCAGATCTGCAT-GCC-3 Ј ). In addition, the Xho I-Cla I apoLp-II/I cDNA fragment from pBK-CMV cDNA clone C5 (10) was cloned into pGEM7-Zf ϩ , using the Xho I and Cla I restriction sites, to yield pGEM7-mod2. In a final cloning step, the Xho I-Bam HI fragment from pGEM7-mod2 was cloned into pIZ/V5-His-mod1* using the unique Xho I and Bgl II sites of the latter plasmid. DNA sequencing of this plasmid confirmed that the resulting construct in pIZ/V5-His encodes the apoLp-II/I amino acid residues 1-1,287, joined in frame at the C terminus with a vector-encoded V5 epitope as well as a 6 ϫ His tag ( Fig. 1A ) . Excluding the 21 residue signal peptide (10) , this apoLp-II/I truncation variant corresponds to 38% of the total precursor protein and is referred to as apoLp-II/I-38.
Mutagenesis of apoLp-II/I-38
The basic amino acid residues at the P1, P2, and P4 positions (15) within the predicted furin cleavage site RQKR 720 in apoLp-II/I-38 were changed using the QuickChange Site-Directed Mutagenesis kit (Stratagene), according to the manufacturer's instructions. Mutants (Fig. 1B) were created using the following forward primers, in combination with their complement reverse primers (codons to be modified are underlined; nucleotide positions to be mutated are shown in boldface): QQKR, 5 Ј -ACA-GAGAGATTTGAGAAAACATTC CA ACAGAAACGATCGGTTTC-3 Ј ; DQKR, 5 Ј -CAGAGAGATTTGAGAAAACATTC GAC CAGAAA-CGATCGGTTTCAAAAGATGC-3 Ј ; RQAR, 5 Ј -GAGATTTGAGA-AAACATTCAGACAG GC ACGATCGGTTTCAAAAGATGCTG-3 Ј ; RQKQ, 5 Ј -CACAGAGAGATTCGAGAAGACATTCAGACAGAAA-C A ATCGGTTTC-3 Ј ; QQAQ, 5 Ј -CACAGAGAGATTCGAGAAGA-CATTC CA ACAG GC AC A ATCGGTTTC-3 Ј . The forward and reverse primers were used in a PCR procedure of 18 cycles (1 min at 95 Њ C, 45 s at 58 Њ C, and 14 min at 68 Њ C) with 10 ng of the apoLp-II/ I-38 construct as the DNA template. After Dpn I digestion, the reaction contents were used to transform into XL1-Blue cells (Stratagene). Single zeocin-resistant colonies were cultured and plasmids were isolated. The introduction of mutations in these plasmids was verified by DNA sequencing.
Stable expression of apoLp-II/I-38 constructs in the Sf9 cell line
Spodoptera frugiperda Sf9 cells were maintained in adherent culture in serum-free Insect-Xpress medium (Cambrex) in polystyrene flasks (Greiner) at 27 Њ C in a humidified atmosphere and passed twice each week. Transfections with the wild-type and mutant apoLp-II/I-38 constructs were performed using Cellfectin reagent (Invitrogen) according to the manufacturer's instructions. Stable transformants were selected using 400 g/ml zeocin (Cayla) and maintained at 100 g/ml zeocin. Experiments were performed in 25 cm 2 flasks with cells grown to 80% confluence. Incubations with the furin inhibitor decanoyl-Arg-ValLys-Arg-chloromethyl ketone (decRVKRcmk; Bachem) were performed by including either the inhibitor or its solvent methanol in fresh culture medium for 6 h. Culture media were collected and cleared from whole cells and cellular debris by centrifugation (1,000 g , 10 min; 22,000 g , 10 min, 4 Њ C), and analyzed for apoLp-II/I-38 and cleavage products by immunoblotting.
In vitro incubation of L. migratoria fat body tissue
L. migratoria were reared in cages under crowded conditions at 30 Њ C, 40% relative humidity, a light-dark cycle of 12 h/12 h, and a diet of reed grass supplemented with rolled oats. Fat bodies were dissected from day 9 adult males, separated in two halves along the length, and rinsed in saline buffer (10 mM HEPES, 150 mM NaCl, 10 mM KCl, 4 mM CaCl 2 , 2 mM MgCl 2 , pH 7.0). Subsequent incubations were performed in a shaking water bath at 32 Њ C. After washing for 1 h at 32 Њ C in 4 ml of saline buffer, halves of six fat bodies were transferred to 250 l of fresh saline buffer with 30 Ci of [ 35 S]Met/Cys (Promix; Amersham) supplemented with either 100 M decRVKRcmk or an equivalent volume of its solvent methanol. Proteins in the incubation medium were analyzed for apoLp-II/I and cleavage products by immunoblotting.
Density gradient analysis
The buoyant density of secreted apoLp-II/I and cleavage products was compared by subjecting the incubation media of decRVKRcmk-treated and control fat body tissue to KBr density gradient ultracentrifugation (13) . After gravimetric analysis of density, fractions were assessed for the presence of apoLp-II/I and cleavage products by immunoblotting. Radiolabeled proteins on the blot were visualized by phosphorimaging on a Molecular Imager FX system with Quantity One software (Bio-Rad).
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Immunoblot analysis of apoLp-II/I and cleavage products
Proteins were precipitated from incubation media by the addition of TCA to a concentration of 5%. Pellets were resuspended and heated (10 min at 95 Њ C) in Laemmli sample buffer that was modified by the addition of 5% (v/v) 1 M Tris to circumvent acidification by residual TCA. Protein samples were separated using SDS-PAGE (9% slab for transfected cell culture media; 4-10% slab for fat body tissue incubation media). Precision Plus Protein Dual Color Prestained Standards (Bio-Rad) were used as a protein molecular mass marker, and isolated wild-type L. migratoria HDLp (6) was used as a positive control. Proteins were transferred to a polyvinylidene difluoride membrane (Millipore), and subsequent immunostaining was performed as described (16) . Primary antibodies (1:10,000 dilution) were monoclonal ␣ -V5 (Invitrogen), polyclonal ␣ -II or ␣ -I (17), or polyclonal ␣ -IIC and ␣ -IN (raised in rabbits against the peptides CKSLYNRITERFEKT-FRQKR and SVSKDAVDNIRQQAYKSLLC, respectively, which correspond to the C terminus of apoLp-II and the N terminus of apoLp-I, excluding the terminal cysteines). Alkaline phosphataseconjugated goat anti-rabbit or goat anti-mouse IgG (Jackson ImmunoResearch Laboratories) was used as a secondary antibody (1:10,000 dilution).
Modeling of L. migratoria apoLp-II/I
The L. migratoria apoLp-II/I sequence was used to identify homologous proteins and conserved domains using the web-based BLASTp program from the National Center for Biotechnology (18) . The default settings were used for the BLASTp search. The most significant matches were to sequences from apoLp-II/I, apoB, and vitellogenin, including silver lamprey lipovitellin. Sequence homologies were located within the first 1,000 amino acid residues.
The alignment program CLUSTAL W (19) was used to align the homologous N-terminal regions of silver lamprey lipovitellin, human apoB-100, and L. migratoria apoLp-II/I. This alignment was used to generate the structural model of the first 1,009 amino acids (excluding the signal peptide) of locust apoLp-II/I using the program Modeller6 (20) , based on the crystal structure of silver lamprey lipovitellin (PDB 1LSH) (21) and an all atom model for apoB (22) . To eliminate steric problems and to optimize bond lengths and angles, the apoLp-II/I model was subjected to 250 steps of steepest descent energy minimization using the DISCOVER program package from INSIGHT2 (Accelerys, Inc.). A graphic representation of the model was generated by the Swiss-PdbViewer (23).
RESULTS
Expression and proteolytic processing of apoLp-II/I-38 by Sf9 cells
To study the sequence characteristics of apoLp-II/I that enable posttranslational cleavage, an apoLp-II/I truncation was recombinantly expressed in the insect Sf9 cell line, which expresses a furin homolog (24) . The construct used encodes the N-terminal 38% of apoLp-II/I (Fig. 1A) . This apoLp-II/I-38 polypeptide includes the signal peptide, the complete sequence for apoLp-II with the consensus substrate sequence for furin, RQKR 720 , followed by 567 N-terminal residues from apoLp-I, fused to the V5 epitope and a 6 ϫ His tag (referred to as apoLp-I 567/V5 ).
Stable transfection of Sf9 cells with this apoLp-II/I-38 . This similar size indicates that recombinant apoLp-II is similarly glycosylated as wild-type apoLp-II. Indeed, deglycosylation with endoglycosidase H resulted in a single additional apoLp-II immunoreactive band with a decreased molecular mass of Ϯ 3 kDa (see supplementary Fig. I ), which is similar to that reported for wild-type locust apoLp-II (6). Moreover, the similar migration behavior of recombinant and wild-type apoLp-II indicates that the cleavage of apoLp-II/I-38 proceeds identical to that in fat body (6, 10) . Expression of a construct expressing the N-terminal 33% of apoLp-II/I in Sf9 cells, and apoLp-II/I-38 in Drosophila melanogaster S2 cells, also resulted in the secretion of the two expected apoLp-II/I cleavage products (data not shown). Recombinant apoLp-II/I-38 is cleaved at the same site as apoLp-II/I in L. migratoria . The ␣ -IIC and ␣ -IN antibodies, raised against synthetic oligopeptides of the sequences that flank the cleavage site N-and C-terminally, specifically recognize recombinant apoLp-II and apoLp-I 567/V5 , respectively ( Fig. 2A, lanes 3 and 4) . In addition, mutation of the three basic residues in the putative furin cleavage site (yielding the mutant designated QQAQ 720 ; Fig. 1B ) results in the secretion of uncleaved apoLp-II/I-38 ( Fig.  2B) , as shown by the single immunoreactive band obtained with ␣ -II, ␣ -IIC, ␣ -I, ␣ -IN, and ␣ -V5 antibodies at ‫ف‬ 145 kDa (Fig. 2B, lanes 1-5, respectively) , similar to the combined molecular mass of apoLp-II and apoLp-I 567/V5 . The limited immunoreactivity of ␣ -IIC antibody against mutant apoLp-II/I (Fig. 2B, lane 2) likely relates to the introduced mutations. In further experiments, the degree of apoLp-II/I-38 cleavage was quantified using ␣ -V5 antibody. Thus, Sf9 cells cleave recombinant apoLp-II/I-38 into apoLp-II and apoLp-I 567/V5 at the consensus substrate sequence for furin, similar to apoLp-II/I in locust fat body. These results validate the use of this expression system to characterize apoLp-II/I cleavage.
The secreted recombinant apoLp-II/I-38 cleavage products apoLp-II and apoLp-I 567/V5 were further characterized for complex formation and lipidation. The coelution of apoLp-II with apoLp-I 567/V5 after affinity chromatography suggests that both cleavage products can form a complex (see supplementary Fig. II) . Upon density gradient ultracentrifugation, the cleavage products apoLp-II and apoLp-I 567/V5 were found together in the fractions with densities between 1.20 and 1.25 g/ml, as was uncleaved mutant apoLp-II/I-38 (QQAQ 720 ) (see supplementary Fig.  III) . These results indicate that the secreted recombinant apoLp-II/I-38 products are poorly lipidated. Therefore, the hypothesized role for apoLp-II/I cleavage in lipidation was assessed in L. migratoria fat body tissue, whereas the present expression system was used to characterize apoLp-II/I cleavage. 
An inhibitor implicates PCs in the cleavage of recombinant apoLp-II/I
DecRVKRcmk is a modified tetrapeptide that irreversibly inhibits a wide range of PCs, including furin (25) and Sfurin, the furin homolog characterized from the insect Sf9 cell line (24) . Incubation of Sf9 cells, transfected with the apoLp-II/I-38 construct, with micromolar concentrations of decRVKRcmk resulted in the secretion of uncleaved apoLp-II/I-38, whereas secretion of both apoLp-II and apoLp-I 567/V5 was concomitantly and dose-dependently decreased, as judged by the immunoreactivity of ␣ -V5 ( Fig. 3 ) and ␣ -II (data not shown). Based on the amount of secreted protein, cleavage appeared to be prevented for up to 90% at a concentration of 10 M decRVKRcmk.
The sensitivity to decRVKRcmk indicates the involvement of a PC in the cleavage of apoLp-II/I.
A consensus substrate sequence for furin is required to efficiently process recombinant apoLp-II/I
To provide further evidence for the involvement of PCs in apoLp-II/I-38 cleavage, a negatively charged amino acid was introduced at position P4 (Fig. 1B) , which is expected to disturb binding by PCs via charge repulsion at the S4 binding pocket (26) (27) (28) . As demonstrated by immunoblot analysis of media from stably transfected Sf9 cells using ␣ -V5 antibody, introduction of Asp at the P4 position (R to D; DQKR 720 ) completely prevented cleavage ( Fig. 4A ) , implicating the involvement of a PC in the cleavage of apoLp-II/I.
To further identify the sequence that directs the cleavage of apoLp-II/I, the basic residues in the furin consensus substrate sequence of apoLp-II/I-38 (RQKR 720 ) were mutated to neutral (uncharged) amino acids (Fig. 1B) . Mutagenesis at the P1 position (R to Q; RQKQ 720 ) abrogated cleavage of apoLp-II/I-38 (Fig. 4B) . In contrast, mutation of the cleavage site residues at the P2 (K to A; RQAR 720 ) or P4 (R to Q; QQKR 720 ) position prevented cleavage only partially, reminiscent of the inefficient cleavage at imperfect cleavage sites described for mammalian furins (26, 29) . Again, impairment of cleavage did not hamper the secretion of truncated apoLp-II/I by the recombinant expression system (Fig. 4B ). These results demonstrate that efficient apoLp-II/I cleavage in Sf9 cells requires the presence of the preferred consensus substrate sequence for furin, R-X-K/R-R, in apoLp-II/I. This indicates the involvement of an insect furin in apoLp-II/I cleavage.
Uncleaved native apoLp-II/I is secreted and forms a stable lipoprotein
To validate the involvement of an insect furin in lipophorin biosynthesis, and to establish the importance of cleavage for (apo)lipoprotein secretion in a physiological situation, fat body tissue from adult male locusts was treated in vitro with decRVKRcmk. Experiments showed the release of large amounts of HDLp that had adhered to fat body tissue. Therefore, [ 35 S]Met/Cys was included in incubation media to label newly biosynthesized proteins.
To identify secreted apoLp-II/I, incubation media were submitted to density gradient ultracentrifugation, and the resulting fractions were analyzed for radiolabeled proteins by phosphorimaging. Compared with control-treated fat body tissue, incubation with 100 M decRVKRcmk resulted in the appearance of an additional radiolabeled band of high molecular mass and a concomitant decrease in the putative apoLp-I, in fractions with an average buoyant density of 1.12 Ϯ 0.01 g/ml ( Fig. 5A ) , identical to the density previously reported for wild-type HDLp (13) . The identity of the radiolabeled proteins in these fractions as apoLp-II/I and apoLp-I was confirmed by immunoblotting with ␣ -I (Fig. 5B) . Although apoLp-II could not readily be identified among other labeled proteins, immunoblotting demonstrated its presence in the same fractions as apoLp-II/I and apoLp-I (data not shown). The sensitivity of apoLp-II/I cleavage to decRVKRcmk incubation ( ‫ف‬ 60% with 100 M inhibitor; Fig. 5A ) was reduced in the fat body, compared with the recombinant expression system ( ‫ف‬ 90% with 10 M inhibitor; Fig. 3 ). This difference may reflect reduced delivery of decRVKRcmk within the fat body, as the hydrophobic decanoyl group of this inhibitor may cause it to accumulate at the surface of the lipid droplets in this tissue. Thus, fat body tissue can secrete uncleaved apoLp-II/I with a buoyant density identical to wild-type HDLp. Gel filtration chromatography indicates that this secreted apoLp-II/I forms particles with a molecular size identical to wild-type HDLp (data not shown). Together, these results demonstrate that fat body can secrete uncleaved apoLp-II/I that has been integrated in a high density lipoprotein similar to wild-type HDLp. Apparently, the biosynthesis as well as secretion of insect lipoprotein can occur independently of apoLp-II/I cleavage.
Homology modeling of apoLp-II/I indicates the position of the cleavage site
The ability of uncleaved apoLp-II/I to form a lipoprotein highlights the structural homology between insect and mammalian apoB-containing lipoproteins in the region of cleavage, but it also provokes questions regarding its function. To obtain a better understanding of the structural consequences of cleavage, L. migratoria apoLp-II/I was modeled to the available homologous structures, the lipovitellin crystal structure (21) and an apoB model (22) . The obtained apoLp-II/I model encompasses amino acids 22-1,030 and therefore the complete LLT domain. This apoLp-II/I sequence can form a structure similar to that of the corresponding lipovitellin and apoB regions, as indicated by the recognition of three antiparallel ␤-sheets (␤A, ␤B, and ␤C) and an extensive ␣-helical structure (Fig. 6) . The ␤A and ␤B sheets face each other to form a putative lipid pocket and are partly surrounded by the ␣-helical region. The ␤C sheet is curved, resulting in a barrel-like structure, which is situated above the putative lipid pocket. The apoLp-II/I cleavage site, located between residues 720 and 721, was situated in an extended loop region (residues 669-748) that connects two ␤-strands of the ␤A sheet at the base of the putative lipid pocket. This region could not be modeled confidently. The corresponding sequence was not resolved in the crystal structure of silver lamprey lipovitellin either (21) , which is suggestive of structural flexibility in this region of lipovitellin and possibly also in the region of apoLp-II/I cleavage. According to the present model, apoLp-II includes the ␤C sheet, the ␣-helical region, and most of the ␤A sheet, whereas apoLp-I consists of two distal ␤-strands from the ␤A sheet, the full ␤B sheet, and further unmodeled C-terminal sequences.
DISCUSSION
It is well established that insect lipoproteins contain two apolipoproteins, apoLp-I and apoLp-II, that are derived from their common precursor protein apoLp-II/I (6, (8) (9) (10) (11) . In the present study, we identified and characterized the cleavage site in L. migratoria apoLp-II/I using an insect recombinant expression system of Sf9 cells and demonstrated that its cleavage likely involves an insect furin. As locust fat body can secrete uncleaved apoLp-II/I in the form of a lipoprotein particle with a buoyant density and molecular mass identical to wild-type HDLp, we conclude that cleavage of apoLp-II/I by insect furin is not required for the biosynthesis or the secretion of this insect lipoprotein.
The involvement of an insect furin in the cleavage of L. migratoria apoLp-II/I is indicated by three results. First, apoLp-II/I cleavage in both the Sf9 recombinant expression system and locust fat body can be inhibited by decRVKRcmk, which specifically inhibits PCs (25) , including Sfurin, the furin homolog characterized from the insect Sf9 cell line (24) . Second, cleavage is completely prevented by mutation of the basic amino acid residue (Arg) at the P4 position to a negatively charged amino acid residue (Asp). Based on the presence of a negatively charged residue at the S4 substrate binding pocket of PCs, this mutation is predicted to impair the substrate interaction via charge repulsion (26) (27) (28) . Third, complete proteolytic processing requires an intact furin consensus substrate sequence with basic amino acid residues at P1, P2, and P4. Mutation of any of these sites into amino acids neutral of charge results in the secretion of uncleaved apoLp-II/I, yet some cleavage does occur in the P2 (Lys→Ala) and P4 (Arg→Gln) mutants. Mammalian furin is known to cleave, with reduced activity, at sequences that partially match the preferred R-X-K/R-R substrate sequence (26, 29) . Likewise, the partial cleavage in these P2 and P4 mutants may result from limited activity of furin at nonideal sites. Together, these results indicate cleavage of apoLp-II/I by an insect furin.
Several furin homologs have been identified in insects. In D. melanogaster, cleavage activity and homology have been demonstrated for the dfurin1 and dfurin2 gene products (30) (31) (32) . Furthermore, a furin was cloned from the insect Sf9 cell line (24) . Moreover, a PC with furin-like activity is present in the fat body of Aedes aegypti (33) . However, no putative furin has yet been identified in L. migratoria fat body.
In transfected Sf9 cells as well as locust fat body, uncleaved apoLp-II/I could be secreted in similar amounts as its cleavage products. The recombinant apoLp-II/I-38 cleavage products apoLp-II and apoLp-I 567/V5 appeared to form a complex, yet were not integrated in a high density lipoprotein, in contrast to apoLp-II/I products secreted by locust fat body, as they were recovered in the very high density range upon density gradient ultracentrifugation (see supplementary Figs. II, III) . The poor lipidation of the apoLp-II/I-38 truncation products is in agreement with the decreased lipidation observed for apoB truncations (1, 22) but may also reflect the absence of cofactors for lipidation in the present expression system. Therefore, the possible role of cleavage in the lipidation and secretion of insect lipoprotein was investigated in locust fat body. Here, decRVKRcmk treatment resulted in the secretion of uncleaved apoLp-II/I that formed a stable high Fig. 6 . Model of L. migratoria apoLp-II/I. The model of locust apoLp-II/I includes amino acid residues 22-1,030 and was constructed based on sequence homology with silver lamprey lipovitellin and human apolipoprotein B, for which an all atom structure and a model are available, respectively (21, 22) . The structures that are part of apoLp-I and apoLp-II after apoLp-II/I cleavage are marked in shades of blue and yellow, respectively. The three ␤-sheets are indicated by ␤A, ␤B, and ␤C. N and C mark the amino-and carboxyl-terminal sides of the modeled region, respectively. The arrows indicate the ␤-strands at the base of the putative lipid pocket that are connected by amino acid residues 669-748. ApoLp-II/I is cleaved within this region, between residues 720 and 721.
by guest, on www.jlr.org Downloaded from density lipoprotein, as indicated by its density and molecular mass identical to wild-type HDLp. Consequently, the uncleaved precursor apoLp-II/I can function as a single apolipoprotein in the formation of lipoprotein, like its mammalian homolog apoB. Thus, apoLp-II/I can be lipidated to form a high density lipoprotein, irrespective of its cleavage.
The lipidation of apoB starts cotranslationally in the rough endoplasmic reticulum and is completed posttranslationally in the smooth endoplasmic reticulum and/or cis-Golgi network, possibly by fusion with an intralumenal lipid droplet (1, 2) . The lipidation process starts with the lipidation of the lipid pocket in the apoB LLT domain and requires the lipid transfer activity of MTP (1, 2) . Based on the homology between apoB and apoLp-II/I (3, 4) as well as the discovery of an insect MTP (12) , insect lipoprotein assembly may also occur early in the secretory pathway. However, cleavage by furin homologs is performed late in the secretory pathway, mainly in the transGolgi network (34) . Therefore, we propose that insect lipoprotein biosynthesis by the fat body involves lipidation of apoLp-II/I to a lipoprotein first, followed by cleavage of apoLp-II/I into apoLp-I and -II. The occurrence of cleavage before any lipidation might result in the parting of apoLp-I and apoLp-II, and hence impairment of lipoprotein biosynthesis. The uncleaved LLT domain in apoLp-II/I may be essential to enable the first steps in lipidation, as in apoB.
Homology modeling shows that the LLT domain of apoLp-II/I can form a putative lipid pocket. Remarkably, the cleavage site is located in an unresolved loop region between two ␤-strands in the ␤A sheet at the base of this pocket (Fig. 6) . In apoB, the corresponding region is proposed to function in early lipidation events, as it may form a hairpin structure that temporarily closes the basal opening of the lipid pocket by connecting to the ␤B sheet via salt bridges (22) . When the lipid pocket of apoB reaches a certain lipid content during lipoprotein assembly, these salt bridges are proposed to dissociate. This would allow for widening of the V-shaped lipid pocket formed by ␤A and ␤B sheets and the progression of apoB lipidation (22, 35) . The cleavage of apoLp-II/I might represent an alternative structural solution to unlock the lipid pocket and increase the flexibility of the nonexchangeable apolipoprotein, hence allowing for further lipidation of the lipoprotein particle. Interestingly, insects can lipidate circulating HDLp to a low density lipophorin (LDLp) during conditions that require enhanced lipid transport (e.g., long-term flight and vitellogenesis) (36, 37) . Therefore, apoLp-II/I cleavage may function to enable the formation of LDLp from HDLp.
The apparent conservation of apoLp-II/I cleavage in all insects characterized to date reveals the importance of this processing step. Besides LDLp formation, however, apoLp-II/I cleavage may enable other unique insect lipoprotein characteristics, such as the ability of lipophorin to function as a reusable lipid transporter (36) and to be recycled after endocytic uptake by an insect member of the low density lipoprotein receptor (LDLR) family (16) . Vitellogenin, another ligand of this receptor family, is homologous to apoB and apoLp-II/I, and is also cleaved at a furin consensus substrate sequence in the LLT domain during biosynthesis in most insect species, but not vertebrates (38) . Lipophorin, vitellogenin, and LDLR family members are involved in insect vitellogenesis, the transfer of nutrients to the developing oocyte (38) , and perhaps the posttranslational cleavage of apoLp-II/I and vitellogenin facilitates this process (e.g., by enabling receptor binding). In addition, apoLp-II/I cleavage might enable a function for lipophorin in coagulation. Lipophorin has been implicated in this process by its abundant presence in clots (39) (40) (41) (42) , capacity to aggregate (43, 44) , and interactions with other insect hemostasis factors (45) . Moreover, the disappearance of apoLp-I but not apoLp-II from plasma during coagulation (46) suggests that apoLp-II/I cleavage enables distinct roles for apoLp-I and apoLp-II in coagulation.
Cleavage of the insect apoB homolog apoLp-II/I appears to be a molecular adaptation within homologous structures and may have a significant impact on insect lipoprotein function. The possibility of obtaining apoLp-II/I lipoprotein from fat body using a furin inhibitor may aid in establishing the physiological role of apoLp-II/I cleavage. Furthermore, the recombinant expression of truncated apoLp-II/I may be used to explore aspects of insect lipoprotein assembly and structure, such as lipid binding regions in apoLp-I and -II, the role of proteinprotein and lipid-protein interactions in apoLp-I:apoLp-II complex formation and lipoprotein solubility (47) , as well as the cofactors involved in insect lipoprotein biosynthesis. For example, apoB truncations with a length similar to apoLp-II/I-38 can form high density lipoprotein particles upon recombinant expression, but only when cells are supplied with exogenous lipids and (co)express MTP (12, 48) . Likewise, the present recombinant expression system may be used to investigate putative roles for lipid availability and insect MTP homologs in the biosynthesis of insect lipoprotein. 
